APO Research, Inc.

Find your market.

Compare the product scope, applications and research editions relevant to your next decision.

Our research approach
Browse the complete product directory →

9,053 topics, 45,265 reports

Clear all filters

Pharma & Healthcare

Drugs based on Genetic Engineering

Types
Recombinant Growth Factor · Recombinant Coagulation Factor · Recombinant Hormone
Applications
Autoimmune Diseases · Cancers · Metabolic Disorders

5 editions23 December 2025

View 5 research editions

Pharma & Healthcare

Formulation Development Outsourcing

Types
Pre-formulation Services · Formulation Optimization
Applications
Pharmaceutical and Biopharmaceutical Companies · Government and Academic Institutes · Others

5 editions30 December 2025

View 5 research editions

Pharma & Healthcare

Medical Asparaginase

Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also available. Asparaginase was approved for medical use in the United States in 1978. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.

Types
Escherichia coli · Erwinia Chrysanthemi · Pegylated
Applications
Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia · Other

5 editions1 January 2026

View 5 research editions
APO Research, Inc.